Arix Bioscience co-leads $45 million Series B investment round for Harpoon Therapeutics
Arix Bioscience co-leads $45 million Series B investment round for Harpoon Therapeutics - Funding to advance two of Harpoon's immuno-oncology programmes into clinical trials - LONDON, 25 May, 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience …